Multiattribute Decision Analysis and Benefit-Harm Characterization
 View Presentation
*James C. Felli, Eli Lilly & Co. Keywords: Benefit-Harm Characterization Multiattribute decision modeling provides a logical and systematic way of thinking about the tradeoffs and consequences inherent in problems of choice involving multiple objectives. We will discuss the basic concepts of multiattribute decision analysis and apply the approach to the framing, quantification and representation of the benefits and harms associated with a pharmaceutical intervention. We will consider the implications of uncertainty in such models and discuss the value of visualization in communicating clearly with stakeholders.
|
Key Dates
-
November 1, 2012
Online submission opens for session, short course, roundtable luncheon discussion, and Town Hall proposals -
December 31, 2012
Online submission for a session, short course, and Town Hall proposals closes @ 11:59 pm EDT -
February 12, 2013
Organizing/Planning Meeting, Shady Grove, MD -
March 1, 2013
Roundtable submission closes @ 11:59 pm EDT -
April 30 - May 22, 2013
Invited Abstract Submission Open -
June 4, 2013
Online Registration Opens -
August 9 - August 23, 2013
Invited Abstract Editing -
August 23, 2013
Short Course materials due from Instructors -
August 26, 2013
Housing Deadline -
September 9, 2013
Cancellation Deadline and Registration Closes @ 11:59 pm EDT -
September 16 - September 18, 2013
Marriott Wardman Park, Washington, DC
